Oncolytics Biotech's market cap is currently $137.69M. The company's EPS TTM is $-0.05073894; its P/E ratio is ―; Oncolytics Biotech is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
